ArticlePloS one2021

Longitudinal analysis to characterize classes and subclasses of antibody responses to recombinant receptor-binding protein (RBD) of SARS-CoV-2 in COVID-19 patients in Thailand.

Sarunporn Tandhavanant et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.